Glucosylceramide synthetase inhibitors sensitise B-CLL cells to cytotoxic agents without reversing P-gp functional activity.
Main Authors: | Gerrard, G, Butters, T, Mehta, AB, Hoffbrand, A, Hughes, D, Burgess, M, Ganeshaguru, K |
---|---|
Format: | Conference item |
Published: |
2004
|
Similar Items
-
Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
by: Gerrard, G, et al.
Published: (2009) -
Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
by: Norris-Cervetto, E, et al.
Published: (2004) -
Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis
by: Natsuki Kita, et al.
Published: (2024-03-01) -
Glucosylceramide modulates membrane traffic along the endocytic pathway.
by: Sillence, D, et al.
Published: (2002) -
Glucosylceramide modulates membrane traffic along the endocytic pathway
by: Dan J. Sillence, et al.
Published: (2002-11-01)